Effective treatment of hypoglycemia in children with type 1 diabetes: a randomized controlled clinical trial

Lindsay McTavish1, Esko Wiltshire

  • 1Department of Diabetes and Endocrinology, Capital and Coast District Health Board, Wellington, New Zealand.

Pediatric Diabetes
|March 30, 2011
PubMed

Insights

Jellybeans were less effective for treating hypoglycemia in children with type 1 diabetes compared to glucose tablets, orange juice, or sugar mints. Other treatments normalized blood glucose within 15 minutes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Hypoglycemia is a common complication in children with type 1 diabetes.
  • Effective and rapid oral treatments are crucial for managing hypoglycemia during activities like diabetes camp.
  • Previous comparisons of oral hypoglycemia treatments in pediatric populations are limited.

Purpose of the Study:

  • To compare the efficacy of four different oral carbohydrate sources for treating hypoglycemia in children with type 1 diabetes.
  • To evaluate treatments using a standardized weight-based protocol during a structured camp environment.
  • To determine the most effective treatment for rapid blood glucose normalization.

Main Methods:

  • A randomized controlled trial was conducted during a diabetes camp involving 39 children (aged 1-12 years).
  • Four treatments (glucose tablets, jellybeans, orange juice, sugar mints) were administered at a dose of 0.3 g carbohydrate/kg body weight.
  • Blood glucose levels were measured at 0, 2, 5, 10, and 15 minutes post-treatment, with symptom recording.

Main Results:

  • A total of 191 hypoglycemia episodes were analyzed.
  • Jellybeans demonstrated the slowest and lowest blood glucose response compared to glucose tablets, orange juice, and sugar mints.
  • Glucose tablets, orange juice, and sugar mints showed similar efficacy in normalizing blood glucose.
  • Repeat treatment was trended to be more frequent with jellybeans (p=0.058).

Conclusions:

  • Jellybeans are a less effective oral treatment for hypoglycemia in children with type 1 diabetes.
  • Glucose tablets, orange juice, and sugar mints (Mentos dragees®) are similarly effective treatments.
  • A 0.3 g/kg carbohydrate dose effectively resolved hypoglycemia in most children within 15 minutes, excluding jellybeans.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...